Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vertex Pharmaceuticals
Podcast
Looking ahead at the most anticipated drug launches of 2025
This week on "The Top Line," we dig into the 10 biggest potential drug launches of 2025, predicted to rake in a combined $29 billion in 2030 sales.
Andrea Park
,
Eric Sagonowsky
Feb 7, 2025 9:00am
FDA signs off on Vertex's non-opioid pain reliever Journavx
Jan 30, 2025 9:22pm
Top 10 most anticipated drug launches of 2025
Jan 27, 2025 3:00am
2024's top biopharma M&A deals
Jan 13, 2025 3:00am
Vertex wins FDA nod for once-daily cystic fibrosis triplet
Dec 23, 2024 10:58am
Daiichi, BIOSECURE, Amgen—Fierce Pharma Asia
Dec 13, 2024 8:43am